| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |